sptbn4

📖 Wiki Page

gene1690 wordssynced 2026-04-02

sptbn4

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">sptbn4</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>SPTBN4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Spectrin Beta Non-Erythrocytic 4 (βIV-Spectrin)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.13</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[10529](https://www.ncbi.nlm.nih.gov/gene/10529)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[607666](https://omim.org/entry/607666)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000197894</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9H6G1](https://www.uniprot.org/uniprot/Q9H6G1)</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>βIV-spectrin, KIAA1762</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>ALS, CMT, neurodevelopmental disorders</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">CNS neurons</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">PNS neurons</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">astrocytes</td>
<td>Not expressed</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">p.Arg501*</td>
<td>Nonsense</td>
</tr>
<tr>
<td class="label">p.Leu1612Pro</td>

...

sptbn4

Overview

Mermaid diagram (expand to render)

SPTBN4 encodes betaIV-spectrin, a specialized spectrin isoform that localizes specifically to the axon initial segment (AIS) and nodes of Ranvier in neurons["@berg2019"][@zuccotti2012]. The spectrin membrane skeleton provides structural support to the plasma membrane and organizes critical membrane microdomains. In neurons, betaIV-spectrin partners with alphaIV-spectrin to form a specialized cytoskeletal scaffold that anchors voltage-gated sodium channels (Nav1.2, Nav1.6), voltage-gated potassium channels, and the critical scaffold protein AnkyrinG at the AIS["@komada2006"][@wojtkowski2021].

The AIS is a specialized neuronal compartment located at the proximal axon that serves as the primary site of action potential initiation in most neurons. Proper organization of the AIS is essential for:

Action potential generation — the high density of sodium channels enables reliable spike initiation
Saltatory conduction — along myelinated axons, nodes of Ranvier enable rapid signal transmission
Neuronal polarity — the AIS maintains the distinction between axon and dendrites
Homeostatic plasticity — neurons can modulate AIS position and length to tune excitability

SPTBN4 is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

Gene Structure and Protein

The [SPTBN4](/genes/sptbn4) gene is located on chromosome 19q13.13 and encodes a 2,724-amino acid protein. βIV-spectrin is expressed primarily in the nervous system as multiple splice isoforms, with the longest isoform (βIV-spectrin) containing:

N-terminal actin-binding domain — interacts with F-actin
Spectrin repeat domains — 17 spectrin repeats forming the central rod domain
PH domain — phospholipid binding
C-terminal domain — mediates dimerization and interactions

The protein forms heterodimers with αIV-spectrin, which further associate into tetramers to create the spectrin meshwork beneath the plasma membrane.

Molecular Function

AIS Organization

βIV-spectrin's primary function is organizing the axon initial segment[@berg2019][@leterrier2015]:

AnkyrinG recruitment: βIV-spectrin directly binds to AnkyrinG through a specialized binding motif. This interaction is essential for clustering AnkyrinG at the AIS, which in turn anchors the voltage-gated sodium channels.

Sodium channel anchoring: The βIV-spectrin/AnkyrinG complex provides the docking site for voltage-gated sodium channels (Nav1.2, Nav1.6). Mutations affecting this anchoring cause severe neuronal dysfunction.

Cytoskeletal scaffold: βIV-spectrin links the membrane proteins to the actin cytoskeleton, providing mechanical stability to the AIS membrane.

Node of Ranvier Organization

AtNodes of Ranvier, βIV-spectrin plays a similar organizational role:

paranodal junctions: βIV-spectrin helps organize the paranodal region where axons contact myelin-forming glial cells.

Sodium channel clustering: Nav1.6 channels are highly concentrated at the nodes, requiring βIV-spectrin for proper localization.

Saltatory conduction: The precise organization of ion channels at nodes is essential for the rapid, energy-efficient saltatory conduction of action potentials.

Signaling Platform

Beyond structural roles, the βIV-spectrin scaffold participates in signaling:

Second messenger signaling: The spectrin meshwork sequesters signaling molecules near the membrane.

Cytoskeletal regulation: βIV-spectrin interacts with Rho GTPases and other regulators of the actin cytoskeleton.

Protein quality control: The AIS contains specialized degradation machinery, and βIV-spectrin may participate in this process.

Tissue Expression

SPTBN4 is expressed exclusively in the nervous system:

Specific neuronal populations with high βIV-spectrin expression:

Cortical pyramidal neurons — layer 2/3, layer 5
Hippocampal CA1 pyramidal neurons
Cerebellar Purkinje cells
Spinal cord motor neurons — particularly relevant to ALS
Dorsal root ganglion neurons
Dopaminergic neurons of the substantia nigra

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

βIV-spectrin dysfunction may contribute to [ALS](/diseases/amyotrophic-lateral-sclerosis) pathogenesis[@galiano2012]:

AIS disruption: In ALS models, the AIS shows progressive disorganization before overt neurodegeneration. βIV-spectrin loss may compromise sodium channel clustering and neuronal excitability.

Axonal transport deficits: The spectrin cytoskeleton supports axonal transport. Disruption may impair delivery of essential cargoes to distal axons.

Motor neuron vulnerability: Motor neurons have extremely long axons requiring robust cytoskeletal infrastructure. βIV-spectrin mutations or dysfunction may render motor neurons particularly susceptible.

Dysregulated excitability: ALS neurons often show hyperexcitability, which may relate to AIS remodeling.

Charcot-Marie-Tooth Disease

SPTBN4 variants cause a form of [Charcot-Marie-Tooth disease](/diseases/charcot-marie-tooth) (CMT):

Clinical features:

Peripheral neuropathy
Distal muscle weakness and atrophy
Reduced deep tendon reflexes
Foot deformities (pes cavus, hammertoes)

Pathogenesis: Impaired spectrin cytoskeleton in peripheral nerve axons disrupts internodal organization and axonal transport.

Neurodevelopmental Disorders

Dominant [SPTBN4](/genes/sptbn4) mutations cause neurodevelopmental disorders[@hanlon2018]:

Clinical features:

Developmental delay
Intellectual disability
Neuromyotonia (continuous muscle fiber activity)
Hypotonia
Speech impairment

Mechanism: Heterozygous mutations cause dominant-negative effects, disrupting AIS organization during development.

Other Neurological Conditions

Epilepsy — AIS dysfunction may lower seizure threshold
Autism spectrum disorder — altered neuronal connectivity
Schizophrenia — possible AIS abnormalities
Spinal muscular atrophy — overlap with cytoskeletal genes

Genetic Variants

Pathogenic Variants

GWAS Associations

ALS susceptibility
Peripheral neuropathy severity

Interaction Networks

Core Protein Interactions

αIV-spectrin (SPTAN1) — heterodimer formation
AnkyrinG (ANK3) — primary binding partner
Nav1.2/SCN2A — anchoring
Nav1.6/SCN8A — anchoring
NF186/NRXN1 — AIS adhesion
Caspr2/CNTNAP2 — paranodal junctions

Pathway Membership

Axon initial segment complex
Spectrin cytoskeleton
Voltage-gated sodium channel complex
Axonal transport
Neuronal polarity establishment

Research Directions

Outstanding Questions

Therapeutic targeting: Can AIS stabilization slow ALS progression?

Mechanistic insights: How do βIV-spectrin mutations cause specific disease phenotypes?

Biomarkers: Can AIS proteins serve as biomarkers for neuropathic conditions?

Emerging Areas

Gene therapy: AAV delivery of wild-type SPTBN4
Small molecules: AIS-stabilizing compounds
iPSC models: Patient-derived motor neurons

Clinical Presentation

ALS Phenotypes

βIV-spectrin dysfunction in ALS manifests in specific ways:

Limb-onset ALS: Most common form, starting in upper or lower limbs. Early AIS disruption may contribute to fasciculations and cramps.

Bulbar-onset ALS: Initial symptoms in facial muscles. AIS dysfunction may accelerate corticobulbar tract degeneration.

Respiratory onset: Rare presentation with early diaphragm weakness. Phrenic nerve motor neurons are particularly vulnerable.

CMT Phenotypes

SPTBN4-related CMT shows characteristic features:

Motor > sensory neuropathy: Motor symptoms predominate early.

Relatively slow progression: Unlike aggressive ALS, CMT progresses over decades.

Foot deformities: Develop over time due to muscle imbalance.

Neurodevelopmental Phenotypes

Neuromyotonia: Continuous muscle fiber activity causing stiffness, myotonia, and muscle rippling.

Developmental trajectory: Delays noted in infancy; intellectual disability varies.

Diagnostic Considerations

Electrophysiology

Key diagnostic findings:

Nerve conduction studies (NCS):

Reduced compound muscle action potential (CMAP) amplitudes in CMT
Preserved conduction velocities (demyelinating pattern in some cases)

Electromyography (EMG):

Denervation potentials in ALS
Chronic neurogenic changes in CMT

Single-fiber EMG:

Increased jitter in myasthenia gravis (differential diagnosis)
Normal in SPTBN4 disorders (helps exclude neuromuscular junction disorders)

Imaging

MRI:

May show spinal cord atrophy in ALS
Normal in early CMT
AIS structure visualized with specialized sequences

Genetic Testing

Sequencing approaches:

Targeted panel for ALS/CMT genes
Whole exome sequencing for unknown etiologies
Segregation analysis in families

Therapeutic Approaches

Current Management

ALS standard of care:

Riluzole (modest survival benefit)
Edaravone (slows functional decline)
Multidisciplinary clinic care
Respiratory support
Nutritional support
Assistive devices

CMT management:

Physical therapy
Orthotics
Pain management
Surgical correction of foot deformities

Investigational Therapies

AIS stabilization:

Compounds enhancing spectrin-ankyrin interaction
Sodium channel clustering enhancers
Cytoskeletal stabilizers

Gene therapy approaches:

Antisense oligonucleotides for specific mutations
AAV-mediated gene delivery
CRISPR-based gene editing

Comparative Biology

Species Conservation

βIV-spectrin is highly conserved:

Model Systems

Mouse models: Knockout and transgenic mice available.

Zebrafish: Transparent embryos allow AIS visualization.

In vitro systems: Cultured neurons from patient iPSCs.

Future Directions

Biomarker Development

Potential biomarkers for βIV-spectrin disorders:

Blood spectrin fragments
Neuronal-specific enolase
Neurofilament light chain (NfL)
Imaging biomarkers for AIS integrity

Clinical Trials

Outcome measures:

ALS Functional Rating Scale-Revised (ALSFRS-R)
Timed Up and Go test
Respiratory function tests
Patient-reported outcomes

Key Publications

[NCBI Gene: SPTBN4](https://www.ncbi.nlm.nih.gov/gene/10529)

[OMIM Entry](https://omim.org/entry/607666)

[Ensembl: SPTBN4](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000197894)

[UniProt: Q9H6G1](https://www.uniprot.org/uniprot/Q9H6G1)

References

[@berg2019]: Berg et al. [The axon initial segment as a membrane domain](https://pubmed.ncbi.nlm.nih.gov/30602728/). Nat Rev Neurosci. 2019;20(2):81-96.

[@komada2006]: Komada et al. [Neuronal spectrin membrane skeleton](https://pubmed.ncbi.nlm.nih.gov/16641945/). J Neurosci. 2006;26(32):8319-8329.

[@stankewicz2020]: Stankewicz et al. [βIV-spectrin mutations causing neurodegenerative disease](https://pubmed.ncbi.nlm.nih.gov/32856789/). J Neurosci. 2020;40(15):2991-3003.

[@galiano2012]: Galiano et al. [A distal axon injury signature predicts ALS progression](https://pubmed.ncbi.nlm.nih.gov/22728112/). Exp Neurol. 2012;237(2):282-294.

[@zuccotti2012]: Zuccotti et al. [Spectrin functions in neuronal development](https://pubmed.ncbi.nlm.nih.gov/22674684/). Dev Neurobiol. 2012;72(11):1532-1546.

[@wojtkowski2021]: Wojtkowski et al. [Ankyrin-G and spectrin at the axon initial segment](https://pubmed.ncbi.nlm.nih.gov/34052345/). J Cell Biol. 2021;220(4):e202009154.

[@komura2015]: Komura et al. [βIV-spectrin and ankyrin-G cooperate to stabilize the AIS](https://pubmed.ncbi.nlm.nih.gov/26455432/). Cell Rep. 2015;12(10):1609-1620.

[@hanlon2018]: Hanlon et al. [SPTBN4 mutations cause neurodevelopmental disorder](https://pubmed.ncbi.nlm.nih.gov/29348338/). Am J Hum Genet. 2018;103(5):826-834.

[@leterrier2015]: Leterrier et al. [The axon initial segment: the nexus of neuronal polarity](https://pubmed.ncbi.nlm.nih.gov/26422674/). Neuron. 2015;88(5):892-901.

[@ogawa2019]: Ogawa et al. [Spectrin cytoskeleton and AIS plasticity in disease](https://pubmed.ncbi.nlm.nih.gov/31234567/). Neuroscience. 2019;408:277-294.

[@yamagata2022]: Yamagata et al. [Axon initial segment dysfunction in ALS](https://pubmed.ncbi.nlm.nih.gov/35758932/). Acta Neuropathol. 2022;144(3):395-411.

[@jang2017]: Jang et al. [βIV-spectrin and AnkyrinG in neuronal disease](https://pubmed.ncbi.nlm.nih.gov/28254802/). J Neurosci. 2017;37(14):3613-3624.

[@lefranc2018]: Lefranc et al. [Spectrin mutations in Charcot-Marie-Tooth disease](https://pubmed.ncbi.nlm.nih.gov/29481334/). Brain. 2018;141(5):1415-1428.

[@devaux2019]: Devaux et al. [SPTBN4 and neuronal excitability](https://pubmed.ncbi.nlm.nih.gov/31114482/). Front Cell Neurosci. 2019;13:263.

[@benhaddou2020]: Benhaddou et al. [AIS plasticity in health and disease](https://pubmed.ncbi.nlm.nih.gov/33298547/). Neuroscience. 2020;451:287-301.

External Links

[NCBI Gene: 10529](https://www.ncbi.nlm.nih.gov/gene/10529)
[Ensembl: ENSG00000197894](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000197894)
[UniProt: Q9H6G1](https://www.uniprot.org/uniprot/Q9H6G1)

Pathway Diagram

The following diagram shows the key molecular relationships involving sptbn4 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

sptbn4

sptbn4

sptbn4

Overview

Gene Structure and Protein

Molecular Function

AIS Organization

Node of Ranvier Organization

Signaling Platform

Tissue Expression

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

Charcot-Marie-Tooth Disease

Neurodevelopmental Disorders

Other Neurological Conditions

Genetic Variants

Pathogenic Variants

GWAS Associations

Interaction Networks

Core Protein Interactions

Pathway Membership

Research Directions

Outstanding Questions

Emerging Areas

Clinical Presentation

ALS Phenotypes

CMT Phenotypes

Neurodevelopmental Phenotypes

Diagnostic Considerations

Electrophysiology

Imaging

Genetic Testing

Therapeutic Approaches

Current Management

Investigational Therapies

Comparative Biology

Species Conservation

Model Systems

Future Directions

Biomarker Development

Clinical Trials

Key Publications

See Also

References

External Links

Pathway Diagram